Positioned to Expand Patient Access and Accelerate Impact in Rare Diseases Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, today announced …
KalVista Pharmaceuticals, Inc.: Chiesi Group Completes Acquisition of KalVista Pharmaceuticals
Source: Finanznachrichten.de
Read Full Story →
